Nicholas Gerard Smedira

Nicholas Gerard Smedira's AcademicInfluence.com Rankings

Philosophy

#9495

World Rank

#13064

Historical Rank

Logic

#6468

World Rank

#7987

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Nicholas Gerard Smedira's Degrees

Doctorate Medicine University of Chicago

Why Is Nicholas Gerard Smedira Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicholas Gerard Smedira's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Durability of mitral valve repair for degenerative disease. (1998) (564)
Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients (2002) (458)
Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. (2006) (378)
Withholding and withdrawal of life support from the critically ill. (1990) (369)
Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation. (2000) (367)
Unexpected abrupt increase in left ventricular assist device thrombosis. (2014) (361)
Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. (2015) (334)
Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. (2001) (312)
Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. (2013) (291)
Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. (2007) (270)
Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts (2004) (266)
Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. (2012) (265)
Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. (2010) (253)
Does off-pump coronary surgery reduce morbidity and mortality? ☆ ☆☆ (2002) (247)
Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. (1999) (247)
Early results with partial left ventriculectomy. (1997) (236)
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. (2002) (233)
Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. (2009) (227)
Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. (2004) (226)
Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. (1992) (222)
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. (2006) (222)
Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart (2001) (218)
Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. (2008) (216)
Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. (2014) (215)
The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants (2002) (197)
Mitral valve surgery in patients with severe left ventricular dysfunction. (2000) (194)
Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. (2006) (192)
Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. (2014) (191)
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. (2007) (180)
Factors influencing HLA sensitization in implantable LVAD recipients. (1997) (164)
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction (2013) (154)
Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy (2007) (148)
HYPOGAMMAGLOBULINEMIA IN LUNG TRANSPLANT RECIPIENTS (2001) (147)
Reoperation for failure of mitral valve repair. (1997) (144)
Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. (1999) (138)
Postcardiotomy mechanical support: risk factors and outcomes. (2001) (138)
Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices (2014) (137)
Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. (2008) (137)
Repair of anterior leaflet prolapse: chordal transfer is superior to chordal shortening. (1996) (132)
Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. (1998) (129)
Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery: A Cohort Study (2013) (126)
Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator (2013) (125)
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. (2015) (125)
Clinical utility of echocardiography in the management of implantable ventricular assist devices. (2000) (122)
Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. (2010) (122)
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. (2018) (118)
Relationship Between Early Diastolic Intraventricular Pressure Gradients, an Index of Elastic Recoil, and Improvements in Systolic and Diastolic Function (2001) (118)
Global surgical experience with the Acorn cardiac support device. (2003) (116)
Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. (2015) (116)
Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. (2013) (114)
Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. (2013) (112)
Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. (2011) (104)
Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. (2007) (104)
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. (2004) (101)
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. (2006) (101)
Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. (2014) (99)
Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries? (1998) (98)
The atherosclerotic aorta at aortic valve replacement: surgical strategies and results. (2000) (97)
Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans. (2001) (96)
Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. (2004) (96)
Robotic surgical instruments for dexterity enhancement in thoracoscopic coronary artery bypass graft. (1997) (94)
Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. (2010) (93)
Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting (2006) (89)
Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. (2006) (88)
Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve. (2003) (86)
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. (2000) (86)
Long-term results of the Carpentier-Edwards pericardial aortic valve: a 12-year follow-up. (1998) (84)
Prediction of right ventricular dysfunction after left ventricular assist device implantation. (1996) (83)
Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. (2006) (83)
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. (2006) (82)
Preoperative Statin Therapy Is Not Associated with a Reduced Incidence of Postoperative Acute Kidney Injury After Cardiac Surgery (2010) (81)
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies. (2007) (80)
Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. (2008) (77)
Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. (2012) (76)
Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. (2000) (75)
Noninvasive estimation of transmitral pressure drop across the normal mitral valve in humans: importance of convective and inertial forces during left ventricular filling. (2000) (73)
Influence of cardiac contraction and coronary vasomotor tone on regional myocardial blood flow. (1994) (73)
Correlation of Donor‐Specific Antibodies, Complement and Its Regulators with Graft Dysfunction in Cardiac Antibody‐Mediated Rejection (2009) (73)
Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations. (2000) (73)
Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? (1996) (73)
Effect of Timing of Chronic Preoperative Aspirin Discontinuation on Morbidity and Mortality in Coronary Artery Bypass Surgery (2011) (72)
Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? (2002) (69)
Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. (2001) (69)
Significant post‐transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? (2000) (68)
Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. (2001) (68)
Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database. (2010) (64)
Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. (2004) (64)
Extended use of extracorporeal membrane oxygenation after lung transplantation. (2006) (64)
Major bleeding during HeartMate II support. (2013) (64)
Microwave ablation of atrial fibrillation during mitral valve operations. (2002) (63)
Minimally invasive coronary artery bypass grafting: on the beating heart and via limited access. (1997) (63)
Long‐Term Outcomes of Patients With Mediastinal Radiation–Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study (2017) (62)
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. (2006) (62)
The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. (2005) (61)
Does right thoracotomy increase the risk of mitral valve reoperation? (2007) (58)
Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. (2019) (57)
Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1. (2005) (56)
Transplant vasculopathy is associated with increased AlloMap gene expression score. (2007) (56)
Long-term survival, valve durability, and reoperation for 4 aortic root procedures combined with ascending aorta replacement. (2016) (56)
Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. (2003) (55)
Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study (2007) (55)
Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. (2015) (55)
Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data. (2015) (55)
Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging (2009) (54)
Improvement in diastolic intraventricular pressure gradients in patients with HOCM after ethanol septal reduction. (2003) (53)
Bivalirudin Provides Rapid, Effective, and Reliable Anticoagulation During Off-Pump Coronary Revascularization: Results of the “EVOLUTION OFF” Trial (2006) (52)
Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery. (2006) (51)
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. (2005) (50)
Does coronary angiography before emergency aortic surgery affect in-hospital mortality? (2000) (50)
Clinical experience with long-term use of implantable left ventricular assist devices: indications, implantation, and outcomes. (2000) (50)
Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart. (2010) (49)
Lessons learned from balloon aortic valvuloplasty experience from the pre-transcatheter aortic valve implantation era. (2010) (47)
Left ventricular torsional mechanics after left ventricular reconstruction surgery for ischemic cardiomyopathy. (2007) (46)
The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. (2006) (45)
Mechanical circulatory assistance: state of art. (2002) (45)
Bridge to transplant experience: factors influencing survival to and after cardiac transplant. (2010) (45)
Mechanical circulatory support after heart transplantation. (2011) (45)
Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. (2014) (44)
Vitamin K reduces bleeding in left ventricular assist device recipients. (1999) (44)
Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. (2003) (43)
Importance of Mitral Valve Repair Associated With Left Ventricular Reconstruction for Patients With Ischemic Cardiomyopathy: A Real-Time Three-Dimensional Echocardiographic Study (2003) (43)
Off-pump reoperative coronary artery bypass grafting by thoracotomy: patient selection and operative technique. (2001) (43)
HLA sensitization in ventricular assist device recipients: does type of device make a difference? (2004) (42)
Failure modes of the Carpentier-Edwards pericardial bioprosthesis in the aortic position. (2006) (42)
Why we need more septal myectomy surgeons: An emerging recognition (2017) (42)
Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy. (2015) (40)
Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. (2009) (39)
Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection. (2015) (39)
Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial Fibrillation (2018) (39)
HLA and MICA allosensitization patterns among patients supported by ventricular assist devices. (2013) (38)
Is anterior leaflet repair always necessary in repair of bileaflet mitral valve prolapse? (1999) (38)
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. (2022) (38)
Reduced survival in women after valve surgery for aortic regurgitation: effect of aortic enlargement and late aortic rupture. (2000) (36)
Real-Time Three-Dimensional Echocardiographic Study of Left Ventricular Function After Infarct Exclusion Surgery for Ischemic Cardiomyopathy (2000) (35)
Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria (2018) (35)
Coregistered MR imaging myocardial viability maps and multi-detector row CT coronary angiography displays for surgical revascularization planning: initial experience. (2005) (35)
Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy. (2013) (33)
Bench repair of donor mitral valve before heart transplantation. (1996) (33)
Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. (2005) (33)
Usefulness of real-time three-dimensional echocardiography for evaluation of myectomy in patients with hypertrophic cardiomyopathy. (2004) (33)
Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. (2014) (32)
Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: Relationship to outcomes. (2015) (31)
Aortic allograft valve reoperation: surgical challenges and patient risks. (2008) (31)
Cytoskeletal structure and recovery in single human cardiac myocytes. (2004) (31)
Implantable left ventricular assist device for patients with postinfarction ventricular septal defect. (2002) (31)
Papillary muscle realignment for symptomatic left ventricular outflow tract obstruction. (2008) (31)
Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support. (1996) (31)
Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures. (2011) (31)
Mechanical circulatory support for heart failure: past, present and a look at the future (2013) (31)
Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States. (2019) (31)
Decay-accelerating factor expression may provide immunoprotection against antibody-mediated cardiac allograft rejection. (2008) (30)
Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis. (2017) (29)
Determinants of Ischemic Mitral Regurgitation in Patients with Chronic Anterior Wall Myocardial Infarction: A Real Time Three‐Dimensional Echocardiography Study (2006) (29)
Asymmetry of systolic anterior motion of the mitral valve in patients with hypertrophic obstructive cardiomyopathy: a real-time three-dimensional echocardiographic study. (2006) (29)
Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. (2006) (28)
Balloon aortic valvuloplasty as a bridge to aortic valve replacement in critically ill patients. (1993) (28)
Permanent mechanical circulatory support with an implantable left ventricular assist device. (1997) (28)
Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. (2005) (28)
Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction (2017) (28)
Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching. (1998) (26)
Contemporary outcomes of outpatients referred for cardiac transplantation evaluation to a tertiary heart failure center: impact of surgical alternatives. (2004) (26)
Outcomes associated with surgical management of infections related to the HeartMate II left ventricular assist device: Implications for destination therapy patients. (2012) (25)
Quantitation and Distribution of β-tubulin in Human Cardiac Myocytes (2002) (25)
Long-term outcomes and clinical predictors for pacing after cardiac transplantation. (2009) (25)
Doppler echo evaluation of pulmonary venous-left atrial pressure gradients: human and numerical model studies. (2000) (25)
Mechanical circulatory support for acute heart failure. (2001) (25)
The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation. (2007) (24)
The Carbomedics Top Hat supraannular aortic valve: a multicenter study. (2003) (24)
Impact of Donor High-Risk Social Behaviors on Recipient Survival in Cardiac Transplantation (2010) (24)
Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study. (2005) (24)
The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound. (2004) (24)
Implantable LVAD insertion in patients with previous heart surgery. (2000) (23)
Small Intestinal Submucosa Intracardiac Patch: An Experimental Study (2005) (23)
Diagnostic value of left ventricular outflow area in patients with hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study. (2008) (22)
Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. (2006) (22)
Post‐transplant ischemic injury is associated with up‐regulated AlloMap gene expression (2007) (22)
The impact of HLA sensitization and donor cause of death in heart transplantation. (2000) (22)
Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. (2005) (21)
The clinical significance of flow cytometry crossmatching in heart transplantation. (2000) (21)
The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. (2006) (21)
Percutaneous lead dysfunction in the HeartMate II left ventricular assist device. (2014) (21)
Use of the Alfieri edge-to-edge technique to eliminate left ventricular outflow tract obstruction caused by mitral systolic anterior motion. (2004) (20)
Trends, Predictors, and Outcomes of Stroke After Surgical Aortic Valve Replacement in the United States. (2016) (20)
Pulmonic valve endocarditis after orthotopic liver transplantation. (1999) (19)
Cardiopulmonary bypass (CPB) for lung transplantation (1996) (19)
Superoxide anion scavengers restore NO-mediated pulmonary vasodilation after lung transplantation. (1999) (19)
Continuously Updated Estimation of Heart Transplant Waitlist Mortality. (2018) (19)
Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation. (2017) (18)
Bench repair of donor aortic valve with minimal access orthotopic heart transplantation. (2005) (18)
Tricuspid valve repair for biopsy-induced regurgitation in a heart transplant recipient. (2005) (18)
Primary adenocarcinoma in a donor lung: evaluation and surgical management. (2003) (17)
Mitral valve replacement in patients with severely calcified mitral valve annulus: surgical technique. (2013) (17)
Effects of surgical ventricular restoration on left ventricular function: dynamic MR imaging. (2006) (17)
Association of Noninvasively Measured Left Ventricular Mechanics With In Vitro Muscle Contractile Performance: A Prospective Study in Hypertrophic Cardiomyopathy Patients (2014) (17)
Transesophageal echocardiography diagnosis of intramural hematoma of the ascending aorta: A word of caution. (1999) (17)
Left ventricular reduction surgery with mitral valve repair. (2000) (17)
Regional Referral System for Patients with Acute Mechanical Support: Experience at The Cleveland Clinic Foundation (2006) (17)
Short-term hemodynamic performance of the mitral Carpentier-Edwards PERIMOUNT pericardial valve. Carpentier-Edwards PERIMOUNT Investigators. (2001) (17)
Study Design and Rationale of VALOR-HCM: Evaluation of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy who are Eligible for Septal Reduction Therapy. (2021) (17)
Preoperative cholesterol levels do not predict explant for structural valve deterioration in patients undergoing bioprosthetic aortic valve replacement. (2006) (17)
Decision support in surgical management of ischemic cardiomyopathy. (2010) (16)
Preoperative risk factors for mortality after biventricular assist device implantation. (2007) (16)
Vascular rejection in cardiac transplantation. (1999) (15)
Mitral valve replacement with a calcified annulus (2003) (15)
A case of fatal West Nile virus meningoencephalitis associated with receipt of blood transfusions after open heart surgery. (2003) (15)
Blunt traumatic rupture of a mitral papillary muscle head. (1996) (14)
Survival is not compromised in donor hearts with echocardiographic abnormalities. (2007) (14)
One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation. (2008) (14)
Mitral inertance in humans: critical factor in Doppler estimation of transvalvular pressure gradients. (2001) (14)
Low-Dose 3-Factor Prothrombin Complex Concentrate for Warfarin Reversal Prior to Heart Transplant (2015) (13)
Total artificial heart. (2012) (13)
Outcomes of Cardiac Surgery in Patients With Previous Solid Organ Transplantation (Kidney, Liver, and Pancreas). (2015) (13)
Extracorporeal Life Support as a Post Left Ventricular Assist Device Implant Supplement (1997) (13)
Advances in managing the noninfected open chest after cardiac surgery: Negative‐pressure wound therapy (2019) (13)
Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management. (2017) (13)
Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. (2006) (13)
Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension (2018) (13)
Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient. (2010) (12)
Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy (2021) (12)
Mechanical treatment of heart failure: the growing role of LVADs and artificial hearts. (2003) (12)
Bilateral thoracotomy and inferior sternotomy for bypass grafting after esophagostomy. (1997) (12)
Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease. (2015) (12)
Early and Midterm Risk of Coronary Allograft Vasculopathy in Patients Bridged to Orthotopic Heart Transplantation with Ventricular Assist Devices (2005) (11)
Double-chambered left ventricle due to fibroelastotic membrane: an unusual case. (2012) (11)
Quantitation and distribution of beta-tubulin in human cardiac myocytes. (2002) (11)
Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. (2012) (11)
Outcomes in Guideline‐Based Class I Indication Versus Earlier Referral for Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy (2020) (11)
Does LVAD bridging-to-transplantation increase graft vasculopathy? (1999) (11)
Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: evidence from intravascular ultrasound. (2004) (10)
Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy. (2014) (10)
Age related outcome after implantable left ventricular assist system support. (1996) (10)
EXTRACORPOREAL LIFE SUPPORT AS A SUPPLEMENT POST LEFT VENTRICULAR ASSIST DEVICE IMPLANT (1997) (10)
Acute myocardial infarction after aortic valve endocarditis. (2001) (9)
Mycoplasma hominis prosthetic valve endocarditis: the value of molecular sequencing in cardiac surgery. (2013) (9)
Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends (2019) (9)
Human clinical fitting study of the DexAide right ventricular assist device. (2009) (9)
Images in cardiovascular medicine. Epicardial real-time 3-dimensional echocardiography during septal myectomy for obstructive hypertrophic cardiomyopathy. (2003) (8)
Surgical advances in heart and lung transplantation. (2004) (8)
Bacterial endocarditis and functional mitral stenosis: a report of two cases and brief literature review. (2002) (8)
Venovenous Extracorporeal Life Support for Patients After Cardiotomy (1997) (8)
Mechanical unloading causes recovery of calcium cycling in the failing human heart. (2001) (8)
The effect of recipient hepatitis C virus infection on outcomes following heart transplantation. (2010) (8)
Relationship between baseline resting diastolic function and exercise capacity in patients with hypertrophic cardiomyopathy undergoing treadmill stress echocardiography: a cohort study (2012) (8)
Extracorporeal Membrane Oxygenation in Pulmonary Endarterectomy Patients. (2019) (8)
Temporary Mechanical Support (2001) (7)
Advances and future directions for mechanical circulatory support. (2013) (7)
A Novel Miniature Ventricular Assist Device for Hemodynamic Support (2001) (7)
Smaller, Safer, Totally Implantable LVADs: Fact or Fantasy? (2005) (7)
One heart in 3 patients. (2012) (7)
A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. (2007) (7)
Mechanical unloading decreases the expression of beta-tubulin in the failing human heart. (2001) (6)
Prognosis of patients removed from a transplant waiting list for medical improvement: implications for organ allocation and transplantation for status 2 patients. (2008) (6)
Right Internal Thoracic Artery Patency Is Affected More by Target Choice Than Conduit Configuration. (2021) (6)
Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart (2017) (6)
Surgical Management of Right Aortic Arch with Tailored Surgical Approach (2012) (6)
Cerebral embolism associated with left ventricular assist device support and successful therapy with intraarterial urokinase. (1999) (6)
Hypertrophic cardiomyopathy: A complex disease (2018) (6)
Attrition from heart transplant waiting list for patients on ventricular assist devices is not affected by desensitization strategies. (2007) (6)
How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation? (2017) (6)
Robotic trans‐mitral septal myectomy and papillary muscle reorientation for HOCM combined with or without mitral valve repair: Technical aspects – How we do it (2020) (6)
Left main dissection and thrombosis in a young athlete. (2005) (6)
Different Histopathologic Diagnoses in Patients With Clinically Diagnosed Hypertrophic Cardiomyopathy After Surgical Myectomy. (2019) (5)
Myocardial recovery: a focus on the impact of left ventricular assist devices (2014) (5)
VENO-VENOUS EXTRACORPOREAL LIFE SUPPORT FOR PATIENTS POST CARDIOTOMY (1997) (5)
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study (2022) (5)
Endoscopic tunneling of HeartMate II left ventricular assist device driveline. (2013) (5)
Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient. (2005) (5)
LONG TERM MORTALITY AND MORBIDITY WITH THE USE OF OLDER DONORS IN CARDIAC TRANSPLANTATION: A SINGLE CENTER EXPERIENCE (1998) (5)
Should it stay or should it go? (2016) (5)
Erratum: Do left ventricular assist device (LVAD) bridge-to- transplantation outcomes predict the results of permanent LVAD implantation? (Annals of Thoracic Surgery (2002) 74 (2051-2063)) (2004) (4)
Safety and Efficacy of Ixmyelocel-T, an Expanded Patient-Specific Mixed Cell Product, in Dilated Cardiomyopathy (IMPACT-DCM) (2011) (4)
Catheter fragmentation of massive pulmonary embolus: guidance with transesophageal echocardiography. (1995) (4)
Saying yes or saying no! (2016) (4)
245 Translatable Performance with the Total Artificial Heart: The U.S. Post-Market Study (2012) (4)
HYPOGAMMAGLOBULINEMIA IN HEART TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS, MYCOPHENOLATE, AND PREDNISONE (1999) (4)
Advances in temporary mechanical support for treatment of cardiogenic shock (2015) (4)
Semi-automated analysis of color M-mode echocardiographic images for determining transmitral pressure gradients using a simplified Euler equation (1999) (4)
Myectomy site thrombus formation: an underappreciated source of thromboembolism after septal myectomy. (2002) (4)
The internal cardiac defibrillator for VT on LVAD support. (2001) (4)
Noninvasive assessment of mitral inertness: clinical results with numerical model validation (2001) (4)
Less invasive versus conventional heart valve surgery in patients with severe heart failure. (2014) (3)
Surgical management of massive atrial size mismatch in heart transplantation. (2000) (3)
Heart transplantation in the older recipient: has the time come to reconsider our selection policies? (2001) (3)
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel. (2022) (3)
Surgical advances in donor selection and management for heart and lung transplantation (2005) (3)
Outcomes after resection of primary cardiac sarcoma (2021) (3)
HEPARES RE-EXPOSURE AT HEART TRANSPLANTATION OF LVAD RECIPIENTS WITH HEPARIN-ASSOCIATED ANTI-PLATELET ANTIBODIES (1996) (3)
Characteristics and Longer-Term Outcomes of Contemporary Patients <18 Years of Age with Hypertrophic Cardiomyopathy. (2020) (3)
Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation. (1999) (3)
Noninvasive assessment of mitral inertness [correction of inertance]: clinical results with numerical model validation. (2001) (3)
Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach (2020) (3)
Abnormalities of Mitral Subvalvular Apparatus in Hypertrophic Cardiomyopathy: Role of Intraoperative 3D Transesophageal Echocardiography. (2016) (3)
A Report of Two Cases and Brief Literature Review (2017) (3)
Comprehensive left ventricular outflow tract management beyond septal reduction to relieve obstruction (2021) (3)
Cardiogenic shock after acute myocardial infarction: Successful bridge to transplantation with the implantable left ventricular assist device (1996) (3)
Clinical statement on the requirements for surgeon certification for implantation of durable Ventricular Assist Devices (VADs). (2013) (3)
Evolution and significance of HLA allosensitization during ventricular assist device support. (2001) (3)
Allocating hearts. (2006) (3)
Late diagnosis of multiple fibroelastomas in a 41-year-old woman with hypertrophic cardiomyopathy and atrial fibrillation. (2008) (2)
Mitral valve surgery in patients with severe left ventricular dysfunction q (2000) (2)
Improvement in diastolic suction in patients with hypertrophic obstructive cardiomyopathy after septal ablation (2002) (2)
Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy. (2022) (2)
477 Temporal Trends in Body Mass Index after Implantation with Continuous Flow LVAD (2011) (2)
Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy. (2023) (2)
Cost effectiveness of artificial organ therapies. (1998) (2)
Orthotopic Heart Transplantation through Minimally Invasive Approach (2007) (2)
Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement (2021) (2)
Use of a polytetrafluoroethylene graft to prevent recurrence of saphenous vein graft aneurysm after coronary artery bypass grafting. (2013) (2)
Abstract 9816: Use of the Wearable Cardioverter Defibrillator and Survival After Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction (2011) (2)
PREDICTORS OF LONG-TERM OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS UNDERGOING CARDIOPULMONARY STRESS TESTING AND ECHOCARDIOGRAPHY (2013) (2)
Association of Septal Myectomy With Quality of Life in Patients With Left Ventricular Outflow Tract Obstruction From Hypertrophic Cardiomyopathy (2022) (2)
Mechanical Support After Cardiac Surgery (1998) (2)
Impact of left atrial strain mechanics on exercise intolerance and need for septal reduction therapy in hypertrophic cardiomyopathy. (2021) (2)
Man and machine: understanding the complex physiologic interactions to reduce complications. (2009) (2)
IN VITRO HEMODYNAMIC AND ECHOCARDIOGRAPHIC EFFECT OF LVAD VALVE REGURGITATION (1997) (2)
Apical myectomy in HCM: Time to let the rubber of the operation meet the road of a randomized trial. (2022) (2)
Hospital transfer of patients for LVAD bridge to transplant: is timing really critical to success? (2001) (2)
Atrial myxoma mimicking a clot in transit. (2013) (2)
Malpositioned mechanical mitral valves causing left ventricular outflow tract obstruction. (2010) (2)
Plasma exchange before and after cardiac transplantation. (2001) (2)
278: “Virtual crossmatching” allows the expansion of effective donor pool for HLA-sensitized patients (2006) (2)
226Earlier surgical myectomy vs. waiting for a Class I indication is associated with improved long-term survival in symptomatic hypertrophic obstructive cardiomyopathy patients (2019) (1)
111 Outcomes of Patients with Anthracycline Cardiomyopathy Treated with Mechanical Circulatory Support: Data from the INTERMACS Registry (2012) (1)
PULMONARY HYPERTENSION IS NOT A RISK FACTOR FOR RVAD USE AND DEATH ON LVAD SUPPORT (1996) (1)
ASSOCIATION OF NONINVASIVELY MEASURED LEFT VENTRICULAR MECHANICS WITH IN-VITRO MUSCLE PERFORMANCE: A PROSPECTIVE STUDY OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS UNDERGOING SURGICAL MYECTOMY (2012) (1)
Immediate post-LVAD implant support: two approaches. (2005) (1)
Intermediate results of partial left ventrioulactomy for dilated cardiomyopathy (1998) (1)
Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard. (2022) (1)
Comparison of HLA & MICA Allosensitization Patterns among Patients Supported by Ventricular Assist Devices (VAD) and Patients with No Devices (2013) (1)
Invited commentary. (2011) (1)
Low mortality in ischemic cardiomyopathy treated with coronary artery bypass grafting despite negative viability study (2002) (1)
Bacterial Endocarditis and Functional Mitral Stenosis * (1)
THE RISK OF CORONARY TRANSPLANT VASCULOPATHY IN THE PATIENT BRIDGED WITH A VENTRICULAR ASSIST DEVICE (2004) (1)
Pulmonary thromboendarterectomy in the setting of a mediastinal venous malformation with a congenitally absent left subclavian vein (2017) (1)
Severe Cholestatic Hepatitis In Heart Transplant Recipients Of Hepatitis C Virus (hcv)-antibody Positive (+) Donors (1999) (1)
Outcomes of patients removed from a cardiac transplant waiting list: implications for maximizing a scarce resource (2002) (1)
Discussion of acute heart failure (2001) (1)
Late Onset Infection in Patients with Ventricular Assist Devices: Etiology, Management and Outcomes (2013) (1)
Original article: cardiovascularInvited commentary (2004) (1)
218 IMPACT-DCM: A Randomized, Controlled, Multi-Center Phase II Trial Utilizing Expanded Autologous Bone Marrow as Sole Therapy for Dilated Cardiomyopathy Study Update (2010) (1)
Abstract 11333: Incremental Value of Peak Longitudinal Strain in the Prediction of Right Ventricular Failure after Left Ventricular Assist Device Implantation (2011) (1)
Unusual case of total pulsus alternans that resulted from varying afterload caused by a subclavian artery rupture. (1993) (1)
Transmitral Early Deceleration Time Predicts LV Pressure Changes: Implications for the Non-invasive Estimation of LV Stiffness (1998) (1)
Cardiovascular Surgery Effect of Timing of Chronic Preoperative Aspirin Discontinuation on Morbidity and Mortality in Coronary Artery Bypass Surgery (2011) (1)
192 Safety and Efficacy of Ixmyelocel-T, an Expanded Patient-Specific Mixed Cell Product, in Dilated Cardiomyopathy (IMPACT-DCM) (2012) (1)
EXTRACORPOREAL LIFE SUPPORT AS A BRIDGE TO LEFT VENTRICULAR ASSIST DEVICE (1997) (1)
A Pulmonary Embolism Response Team (PERT) Approach: Early Experience From the Cleveland Clinic (2016) (1)
Early results with the batista procedure for end-stage heart failure (1998) (1)
Abstract 13038: Utility of Left Atrial Strain Mechanics and Stiffness in Patients With Hypertrophic Cardiomyopathy (2020) (1)
Giant saphenous vein graft aneurysm. (2002) (1)
Relationship between systolic and diastolic function with improvements in forward stroke volume following reduction in mitral regurgitation (2001) (0)
Abstract 13757: Dilated Ascending Aorta in Hypertrophic Cardiomyopathy: Incidence and Predictors (2014) (0)
Is The Therapeutic Efficacy of Mycophenolate Mofetil In The Treatment Of Cardiac Allograft Rejection Related To Blood Level (1999) (0)
Cardiac Surgical Procedures in Patients with Cirrhosis (2017) (0)
Hemodynamic, clinical and echocardiographic observations Results of partial left ventriculectomy for dilated cardiomyopathy: (2011) (0)
Risks and Outcomes of Reoperative Cardiac Surgery in Patients with Patent Bilateral Internal Thoracic Artery Grafts. (2021) (0)
Abstract 4354: The Effect of Preoperative Aspirin on Morbidity and Mortality in Coronary Artery Bypass Surgery (2009) (0)
The impact of the ACE insertion polymorphism on the outcome of heart transplantation (2003) (0)
Mitral Valve Pathology in Hypertrophic Cardiomyopathy (2020) (0)
Original articleCardiovascularInvited commentary (2005) (0)
Do All Vads Increase All HLA Antibodies? the Associations Between Ventricular Assist Device (VAD) Type and the Class of HLA Antibody Allosensitization: 1716 (2012) (0)
Mass effect: a lethal complication of ventricular assist devices. (2002) (0)
THE IMPACT OF TRANSPLANTATION ACROSS A POSITIVE CROSSMATCH AND DONOR CAUSE OF DEATH IN HEART TRANSPLANTATION. (1999) (0)
P-493 Are EP studies still useful in the post-madit II era? (2003) (0)
BMI and Survival in Patients Treated With a Continuous Flow Left Ventricular Assist Device as Bridge to Transplant: A Single Center Experience (2010) (0)
81: Timing of Transplant Following Mechanical Circulatory Support in 375 Patients: Lessons from a Single Center Experience (2010) (0)
THREE-DIMENSIONAL ECHOCARDIOGRAPHIC OVERESTIMATES LEFT VENTRICULAR WALL THICKNESS VERSUS CARDIAC MAGNETIC RESONANCE: A PROSPECTIVE STUDY IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS (2020) (0)
Consequences of Long-Term Anticoagulation and Antiplatelet Cessation in Patients on Bleeding Complications (2014) (0)
An unexpected fate: looking beyond the pericardial effusion. (2013) (0)
COMBINED MECHANICAL CIRCULATORY SUPPORT AND RENAL REPLACEMENT THERAPY AS A BRIDGE TO CARDIAC TRANSPLANTATION: 1944 (2010) (0)
Abstract 12054: Unmet Need and Applicability of Transcatheter Mitral Valve Repair with MitraClip in Patients with Severe Symptomatic Mitral Regurgitation (2012) (0)
A needle or a knife? (2018) (0)
Primary Pulmonary Artery Sarcoma Masquerades as Pulmonary Embolism: 20 Year Observational Analysis (2014) (0)
Significant risk for ventricular arrhythmias remains after partial left ventriculectomy (1998) (0)
Abstract 17888: A Dynamically Updated Cardiac Transplant Waitlist Mortality Score (2015) (0)
ONE YEAR POST-TRANSPLANT MONITORING OF DONOR SPECIFIC HLA ANTIBODIES (DSA) IN A HEART TRANSPLANT RECIPIENT TRANSPLANTED AGAINST DSA DETECTED BY FLOW CROSSMATCH AND SOLID PHASE ASSAYS: 1520 (2010) (0)
Pulmonary Thromboendarterectomy Experience at the Cleveland Clinic (2015) (0)
SURGICAL INTERVENTION FOR ACUTE PULMONARY EMBOLISM (2005) (0)
UNPLANNED HOSPITAL READMISSIONS FOLLOWING HEARTMATE® II IMPLANTATION: FREQUENCY, RISK FACTORS, AND IMPACT ON SURVIVAL (2012) (0)
Discussion (2020) (0)
Preoperative BNP Elevation Is Associated with Increased Risk Following CABG: An Analysis from the Nesiritide Administered Peri-Anesthesia in Patients Undergoing Cardiac Surgery (NAPA) Trial (2007) (0)
10 Commandments for Myectomy Treatment of Ventricular Outflow Tract Obstruction and Systolic Anterior Motion of the Mitral Valve (2023) (0)
QS430. Timing to Open-Heart Surgery Post Abdominal Transplant May Affect Post Transplant Survival (2008) (0)
ROLE OF THE RN FIRST ASSISTANT IN THE EXTRACORPOREAL LIFE SUPPORT PROGRAM (1997) (0)
Noninvasive estimation of diastolic intraventricular pressure gradients from color M-mode echocardiography: Intraoperative human validation (2003) (0)
Abstract 2494: Long-term Outcomes for Pacemaker-Requiring Bradyarrhythmias After Cardiac Transplantation: Analysis of the UNOS Registry (2009) (0)
THE INTRA-AORTIC CANNULA PUMP; A NOVEL ASSIST DEVICE FOR HEMODYNAMIC SUPPORT (1999) (0)
10 Commandments to Avoid Systolic Anterior Mitral Leaflet Motion (2023) (0)
BEING AN ELDERLY VAD RECIPIENT: IS IT A RISK FACTOR FOR DEATH DURING THE BRIDGE TO TRANSPLANTATION AND POST-HEART TRANSPLANTATION PERIOD?: 775 (2008) (0)
Disposition of patients referred for cardiac transplantation to a tertiary specialized heart failure center in contemporary clinical practice (2002) (0)
AORTIC ROOT/ASCENDING AORTOPATHY IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS UNDERGOING CARDIAC MAGNETIC RESONANCE (2019) (0)
Abstract 10757: Patient-Reported Quality of Life Outcomes in Hypertrophic Cardiomyopathy Patients (2021) (0)
INCREMENTAL PROGNOSTIC UTILITY OF LATE GADOLINIUM ENHANCEMENT IN HYPERTROPHIC CARDIOMYOPATHY (2017) (0)
P147: A comparative analysis between survivors and non-survivors with cardiac allograft antibody-mediated rejection (2007) (0)
IMPACT OF THE TYPE OF VENTRICULAR ASSIST DEVICE ON THE LONG-TERM DEVELOPMENT OF CORONARY TRANSPLANT VASCULOPATHY (2004) (0)
DONOR HIGH RISK SOCIAL BEHAVIOR AND OUTCOMES IN CARDIAC TRANSPLANTATION: 418 (2008) (0)
Does Everyone Need High Technology Intervention Before They Die? (2022) (0)
Abstract 17075: Outcomes in Radiation Associated Cardiac Disease Patients that present with Coronary Artery Disease: Comparison between PCI and CABG (2014) (0)
COLOR M-MODE ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION (1999) (0)
CHARACTERISTICS AND LONGER-TERM OUTCOMES OF PEDIATRIC PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A TERTIARY CARE CENTER EXPERIENCE (2019) (0)
83: Outcomes of female heart transplant recipients bridged to transplantation with a ventricular assist device (2007) (0)
567: Single-Center Experience Using the Heartmate II Left Ventricular Assist Device as a Bridge to Decision (2010) (0)
539 Higher Incidence of Class II Human Leukocyte Antigen (HLA)-Allosensitization in Patients Supported with Pulsatile Ventricular Assist Devices (VAD) (2012) (0)
Time-Varying Mortality Risk Score for Candidates Awaiting Cardiac Transplantation (2016) (0)
LONG-TERM OUTCOMES OF PATIENTS WITH RADIATION HEART DISEASE UNDERGOING CARDIAC SURGERY: CLINICAL AND ECHOCARDIOGRAPHIC PREDICTORS (2011) (0)
Improvement in Diastolic Intraventricular Pressure Gradients in Patients With Hypertrophic Obstructive Cardiomyopathy After Ethanol Septal Reduction (2003) (0)
USE OF LEFT VENTRICULAR SUPPORT AS A BRIDGE TO TRANSPLANTATION: IMPACT OF AGE ON SURVIVAL.: Abstract# 466 Poster Board #‐Session: P106‐II (2000) (0)
reconstructive surgery Residual high incidence of ventricular arrhythmias after left ventricular (2013) (0)
6-P: VENTRICULAR ASSIST DEVICES (VAD) ARE HIGHLY SIGNIFICANTLY ASSOCIATED WITH CLASS I HLA ALLOSENSITIZATION (2012) (0)
Steep left ventricle to aortic root angle is independently associated with dynamic left ventricular outflow tract gradient in hypertrophic cardiomyopathy: a novel association using 3-dimensional multi-modality imaging (2009) (0)
Integrated oral poster session 2: Fri 2/9 3:00 pmTransplant/immunology IV: Clinical/toleranceP259: No compromised survival in donor hearts with echocardiographic abnormalities (2007) (0)
Hypertrophic Cardiomyopathy Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for (2011) (0)
Diastolic Pressure Gradient€Predicts Outcome in€Patients With Heart Failure and€Preserved Ejection€Fraction (2017) (0)
Abstract 8738: Long-term Outcomes of Catheter Ablation or Surgical Ablation to Eliminate Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy (2010) (0)
Abstract 12056: Factors Affecting the Decision to Undergo Genetic Testing in Patients with Hypertrophic Cardiomyopathy (2011) (0)
781 Performance of the Right Ventricular Failure Risk Score in Patients Supported with a Left Ventricular Assist Device (2012) (0)
Metabolomics Analysis in Chronic Thromboembolic Pulmonary Hypertension (2018) (0)
Abstract 15124: Abnormalities in Papillary Muscle and Mitral Valve Independently Predict Left Ventricular Outflow Tract Gradient in Hypertrophic Cardiomyopathy Patients without Overt Septal Hypertrophy: A Multimodality Imaging Study (2012) (0)
AGE RELATED OUTCOME AFTER IMPLANTABLE LVAS SUPPORT (1996) (0)
IMPROVEMENT IN MULTI-DOMAIN PATIENT-REPORTED OUTCOME SCORES WITH MAVACAMTEN TREATMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE VALOR-HCM STUDY (2023) (0)
Discussion. (2020) (0)
94-P: Kinetics of DSA in a highly sensitized heart transplant recipient transplanted in the face of positive flow crossmatch and DSA (2009) (0)
Alcohol: Keep it moderate. (2019) (0)
Blunt abdominal trauma. (1989) (0)
Invited commentary. (2006) (0)
415: Seeing the future: Strategic decision support for heart transplant (2007) (0)
Microarray analysis of changes in gene expression following LVAD support (2002) (0)
HLA alloantibodies and time of death in cardiac transplantation (2002) (0)
VARIATION IN IN-HOSPITAL OUTCOMES AFTER SURGICAL MYECTOMY AND ALCOHOL SEPTAL ABLATION DONE FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY: COMPARISON OF NATIONWIDE READMISSION DATABASE OF METROPOLITAN HOSPITALS VERSUS A HIGH VOLUME CENTER OF EXCELLENCE (2019) (0)
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy. (2022) (0)
Untoward effect of septal reduction interventions on conduction system in patients with obstructive hypertrophic cardiomyopathy (2002) (0)
Abnormal diurnal pattern of blood pressure in patients with left ventricular assist devices (2002) (0)
Erratum (2021) (0)
Abstract 14699: Patterns of Postoperative Transprosthesis Aortic Valve Gradients Predict Bioprosthetic Structural Valve Deterioration (2015) (0)
ACCELERATED MITRAL ANNULAR CALCIFICATION (MAC) IN PATIENTS WITH FABRY'S DISEASE (FD) (2023) (0)
Reply: To PMID 22858287. (2013) (0)
Abstract 3287: Association Between Morphologic Appearance on Echocardiography and Histopathology in Hypertrophic Obstructive Cardiomyopathy (2009) (0)
STRUT THROUGH THE HEART (2019) (0)
Adding a new dimension to our understanding of continuous-flow physiology. (2015) (0)
TEMPORAL CHANGES IN VARIOUS ECHOCARDIOGRAPHIC PARAMETERS FOLLOWING SURGICAL MYECTOMY IN SEVERELY SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM THE PROSPECTIVE SPIRIT-HCM STUDY (2023) (0)
Hypertrophic cardiomyopathy patients have a steep left ventricle to aortic root angle compared to normal as demonstrated on 3-D Tomographic Imaging: a case-control study (2009) (0)
Abstract 18412: Lactate Dehydrogenase Trends Predict Left Ventricular Assist Device Thrombosis (2015) (0)
Increase in left ventricular assist device thrombosis. (2014) (0)
EARLY AND LATE REJECTION AND HLA SENSITIZATION AT TIME OF HEART TRANSPLANT IN PATIENTS BRIDGED WITH LEFT VENTRICULAR- ASSIST DEVICES (LVAD) (2004) (0)
transplantation Extended use of extracorporeal membrane oxygenation after lung (2013) (0)
Optimal Timing of Heart Transplantation After HeartMate II Left Ventricular Assist Device Implantation (2016) (0)
Abstract 15774: Atrial Fibrillation is a Significant Predictor of Long-term Outcomes in Asymptomatic or Minimally Symptomatic Hypertrophic Cardiomyopathy Patients (2010) (0)
Non-Linearity of the LA Pressure-Volume Relationship: An Intraoperative Echocardiographic Study (1998) (0)
EXERCISE CAPACITY IS AN INDEPENDENT PREDICTOR OF LONG-TERM OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS THAT UNDERWENT EXERCISE ECHOCARDIOGRAPHY (2012) (0)
Downregulation in the Failing Human Heart-Adrenergic Responsiveness and Reverses Receptor β Mechanical Unloading Restores (2001) (0)
HEART TRANSPLANTATION IN THE OLDER RECIPIENT: INITIAL RESULTS OF A SINGLE CENTER EXPERIENCE (1998) (0)
Abstract 16045: Association between Septal Strain Rate Measured by Speckle Tracking Echocardiography and Histopathology in Hypertrophic Cardiomyopathy Patients undergoing Septal Myectomy (2010) (0)
PREDICTORS OF PEAK OXYGEN CONSUMPTION IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS UNDERGOING CARDIOPULMONARY EXERCISE TESTING (2013) (0)
The Pathology of Thromboendarterectomy Specimens from 50 Chronic Thromboembolic Pulmonary Hypertension Patients (2018) (0)
INCREMENTAL PROGNOSTIC VALUE OF NT-PROBNP IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY PATIENTS (2021) (0)
Readmission following discharge on LVAD: implications for permanent support (2003) (0)
Abstract 15426: Comparison of Multimodality Imaging in Mitral Leaflet Lengths in Patients Undergoing Surgical Myectomy: A Prospective Study in Hypertrophic Obstructive Cardiomyopathy Patients (2020) (0)
Commentary: Is length (of the anterior mitral leaflet) important? (2021) (0)
Predictive Value of HLA Antibody Characteristics in Progression of Subclinical Antibody Mediated Rejection in Heart Transplant Recipients (2013) (0)
SURGICAL OUTCOMES FOR THE MANAGEMENT OF CHRONIC PULMONARY THROMBOEMBOLIC DISEASE (2005) (0)
APPROPRIATE AND INAPPROPRIATE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND PREDICTORS (2014) (0)
50th Anniversary Landmark Commentary on Loop FD, Spampinato N, Cheanvechai C, Effler DB. The Free Internal Mammary Artery Bypass Graft: Use of the IMA in the Aorto-to-Coronary Artery Position. Ann Thorac Surg 1973;15:50-5. (2015) (0)
PERFORMANCE OF THE RIGHT VENTRICULAR FAILURE RISK SCORE IN PATIENTS SUPPORTED WITH A LEFT VENTRICULAR ASSIST DEVICE (2012) (0)
Invited commentary. (2010) (0)
Saving 2 lives with 1 operation! (2016) (0)
Intraoperative post-resection assessment of septal myectomy (2022) (0)
THE IMPACT OF PULMONARY ARTERY THROMBOENDARTERECTOMY ON RIGHT VENTRICULAR STROKE WORK INDEX (2006) (0)
MECHANICAL CIRCULATORY SUPPORT AFTER CARDIAC TRANSPLANTATION: THE MODERN ERA: 778 (2008) (0)
HLA ALLOANTIBODIES IN LUNG TRANSPLANTATION (1999) (0)
Redo cardiac surgery in a patient with severe kyphoscoliosis and pectus carinatum: a technical challenge. (2014) (0)
Abstract 13729: Surgical Myectomy Results in Significantly Improved Long-term Event Rate in Hypertrophic Cardiomyopathy Patients With Severe Left Ventricular Outflow Tract Obstruction (2014) (0)
213: Outcomes of patients removed from a heart transplant taiting list (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nicholas Gerard Smedira?

Nicholas Gerard Smedira is affiliated with the following schools:

University of Florida